Flagship Harbor Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Flagship Harbor Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$41.04 - $56.79 $47,113 - $65,194	-1,148 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$36.42 - $57.0 $509 - $798	14 Added 1.23%	1,148 $47,000
Q2 2019 Jul 22, 2019	SELL	$23.32 - $28.12 $163,240 - $196,840	-7,000 Reduced 86.06%	1,134 $30,000
Q4 2018 Jan 28, 2019	SELL	$14.32 - $22.92 $42,960 - $68,760	-3,000 Reduced 26.94%	8,134 $131,000
Q3 2018 Nov 05, 2018	SELL	$13.03 - $21.81 $8,469 - $14,176	-650 Reduced 5.52%	11,134 $231,000
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $177,584 - $263,254	11,784 New	11,784 $179,000
Q4 2017 Jan 24, 2018	SELL	$26.84 - $39.14 $184,766 - $269,439	-6,884 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$29.49 - $38.37 $203,009 - $264,139	6,884	6,884 $260,000

306

157M

828K

317K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.24B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.